Additional file 12: Figure S8. of The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features

Andrea Aloia (3562976); Andreas Bosio (599151); Andreas Schneeweiss (146474); Andreas Trumpp (259351); Annalisa Terranegra (3486953); Bernhard Gerstmayer (3563003); David Agorku (3563018); Evgeniya Petrova (3563009); Franziska Zickgraf (3562979); Jean-Gabriel Judde (3562988); Laura Soldati (484680); Manuel Reitberger (3562991); Marc SĂźtterlin (3563030); Martin Sprick (3562985); Massimo Saini (3563000); Monica Falleni (3562994); Olaf Hardt (3563006); Olivier DĂŠas (3563027); Saskia Spaich (3563015); Sebastian KnĂśbel (3563021); Silvia RĂźberg (3563024); Stefan Tomiuk (831767); Stefano Cairo (3563012); Steve Wagner (695522); Ute Bissels (747002)

Additional file 12: Figure S8. of The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features

Abstract

SSEA4-positive breast cancer cells show decreased expression of miRNAs inhibiting EMT inducers. Expression ratios of the 12 miRNAs targeting the key mesenchymal regulator and indicator genes ZEB1, ZEB2, fibronectin 1, Snail1, Snail2, and Twist. Each bar represents the log2 expression ratio of the SSEA4-positive fraction relative to the SSEA4-negative fraction for the respective tumor model. (TIFF 201 kb

Similar works

Full text

Available Versions

FigShare

oai:figshare.com:article/44517...

Last time updated on 12/02/2018